| Issue Date | Title | Author(s) |
| 2019-11-01 | Investigating the Pathogenesis of Early Stage Squamous Cell Lung Carcinoma Using Murine Models | Sahu, P; Donovan, C; Pickles, S; Chimankar, V; Shukla, S; Gomez, H; Budden, K; Malyla, V; Paudel, KR; Dua, K; Hansbro, P |
| 2003-12-15 | Frequent Loss of Heterozygosity Targeting the Inactive X Chromosome in Melanoma | Indsto, JO; Nassif, NT; Kefford, RF; Mann, GJ |
| 2015-09-01 | Multiple myeloma: A novel tailor-made therapeutic management. | Krishnan, SR; Bebawy, M; Luk, F; Brown, RD; Kwan, YL |
| 2013-10-01 | High discordance rates between sub-areolar and peri-tumoural breast lymphoscintigraphy | Noushi, F; Spillane, AJ; Uren, RF; Cooper, R; Allwright, S; Snook, KL; Gillet, D; Pearce, AM; Gebski, V |
| 2014-01-01 | Physical activity and fitness in women with metastatic breast cancer | Yee, J; Davis, GM; Beith, JM; Wilcken, N; Currow, D; Emery, J; Phillips, J; Martin, A; Hui, R; Harrison, M; Segelov, E; Kilbreath, SL |
| 2014-06-16 | Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer | Chung, L; Moore, K; Phillips, L; Boyle, FM; Marsh, DJ; Baxter, RC |
| 2018-04-23 | The PiGeOn project: Protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer | Best, M; Newson, AJ; Meiser, B; Juraskova, I; Goldstein, D; Tucker, K; Ballinger, ML; Hess, D; Schlub, TE; Biesecker, B; Vines, R; Vines, K; Thomas, D; Young, MA; Savard, J; Jacobs, C; Butow, P |
| 2015-05-01 | Targeting microparticle biogenesis: A novel approach to the circumvention of cancer multidrug resistance | Roseblade, A; Luk, F; Ung, A; Bebawy, M |
| 2019-09-01 | Risk of emergency hospitalisation and survival outcomes following adjuvant chemotherapy for early breast cancer in New South Wales, Australia | Tervonen, HE; Chen, TYT; Lin, E; Boyle, FM; Moylan, EJ; Della-Fiorentina, SA; Beith, J; Johnston, A; Currow, DC |
| 1997-05-01 | Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: A frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial | Augenlicht, LH; Wadler, S; Corner, G; Richards, C; Ryan, L; Multani, AS; Pathak, S; Benson, A; Haller, D; Heerdt, BG |
